6. Harmony Biosciences Holdings Inc. (NASDAQ: HRMY)
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) ranks sixth among the best cheap biotech stocks to buy now, supported by impressive revenue growth and the continued commercial success of its flagship treatment WAKIX. Harmony focuses on developing therapies for neurological disorders, particularly conditions affecting sleep and wakefulness.
The company reported strong financial results for 2025, including fourth-quarter revenue of $243.8 million and total net product revenue of $868.5 million for the year. The performance reflects six consecutive years of revenue growth and profitability, an achievement that distinguishes Harmony within the broader biotechnology sector.
WAKIX, the company’s primary product, continues to gain traction in the treatment of narcolepsy and related disorders. The average number of patients receiving WAKIX increased to approximately 8,500 by the end of the fourth quarter of 2025, marking the third consecutive quarter with significant patient growth.
Management expects WAKIX to surpass the $1 billion annual revenue threshold by 2026, potentially achieving blockbuster status. Such milestones often attract increased investor interest in biotechnology stocks with established commercial platforms.
YOU MUST READ THIS!!! – Top 10 Small-Cap FDA Catalyst Biotech Stocks
Click next to see the following stock...
